IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v14y2016i4d10.1007_s40258-016-0239-0.html
   My bibliography  Save this article

Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany

Author

Listed:
  • I. Aumann

    (Leibniz University of Hanover
    Member of the German Center for Lung Research (DZL))

  • M. Treskova

    (Leibniz University of Hanover)

  • N. Hagemann

    (Leibniz University of Hanover)

  • J.-M. Schulenburg

    (Leibniz University of Hanover
    Member of the German Center for Lung Research (DZL))

Abstract

Background Smoking cessation is a challenging task with a high risk of relapse. Depending on the choice of medication and duration of therapy, the costs of using a smoking cessation aid can be high. Additionally, these costs are not covered by health insurance in Germany. Information on willingness to use (WTU) and willingness to pay (WTP) for smoking cessation aids is valuable for developing different smoking cessation strategies. Objectives The study analyses WTU and WTP for three pharmacological smoking cessation aids (nicotine replacement therapy (NRT), bupropion and varenicline) among young and middle-aged adults in Germany and attempts to determine their major driving factors. Methods Two cross-sectional internet-based surveys of smokers over 18 years of age were conducted in 2014 and 2015 in Germany. Respondents were asked about smoking-related issues and WTU and WTP for each therapy. The contingent valuation method with payment cards was used to measure WTP. Descriptive statistics, logistical regression and accelerated failure-time regression models were performed. Results The total sample size is 505. Half of the respondents are willing to use NRT and one-third are willing to use bupropion and/or varenicline. WTU induces positive WTP; however, the magnitude of WTP is beneath the market price. WTU significantly increases with a higher addiction level and if smokers have previously heard about the therapy. Conclusion This study indicates different points to be considered for policy development. Promotion information and improving awareness about medication aids might increase WTU, and development of monetary incentives for young smokers could create a better chance for successful smoking cessation.

Suggested Citation

  • I. Aumann & M. Treskova & N. Hagemann & J.-M. Schulenburg, 2016. "Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany," Applied Health Economics and Health Policy, Springer, vol. 14(4), pages 441-452, August.
    • Handle: RePEc:spr:aphecp:v:14:y:2016:i:4:d:10.1007_s40258-016-0239-0
    DOI: 10.1007/s40258-016-0239-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40258-016-0239-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40258-016-0239-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Ortiz, Ramon Arigoni & Markandya, Anil & Hunt, Alistair, 2009. "Willingness to Pay for Mortality Risk Reduction Associated with Air Pollution in Sao Paulo," Revista Brasileira de Economia - RBE, EPGE Brazilian School of Economics and Finance - FGV EPGE (Brazil), vol. 63(1), April.
    2. Joachim Marti, 2012. "Assessing preferences for improved smoking cessation medications: a discrete choice experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 533-548, October.
    3. Klose, Thomas, 1999. "The contingent valuation method in health care," Health Policy, Elsevier, vol. 47(2), pages 97-123, May.
    4. David L. Weimer & Aidan R. Vining & Randall K. Thomas, 2009. "Cost–benefit analysis involving addictive goods: contingent valuation to estimate willingness‐to‐pay for smoking cessation," Health Economics, John Wiley & Sons, Ltd., vol. 18(2), pages 181-202, February.
    5. WHO World Health Organization, 2013. "Who Report On The Global Tobacco Epidemic, 2013," University of California at San Francisco, Center for Tobacco Control Research and Education qt5t06910t, Center for Tobacco Control Research and Education, UC San Francisco.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Rashmita Basu, 2013. "Willingness-to-pay to prevent Alzheimer’s disease: a contingent valuation approach," International Journal of Health Economics and Management, Springer, vol. 13(3), pages 233-245, December.
    2. Alene Sze Jing Yong & Yi Heng Lim & Mark Wing Loong Cheong & Ednin Hamzah & Siew Li Teoh, 2022. "Willingness-to-pay for cancer treatment and outcome: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 1037-1057, August.
    3. Marc Fleurbaey & Stéphane Luchini & Christophe Muller & Erik Schokkaert, 2013. "Equivalent Income And Fair Evaluation Of Health Care," Health Economics, John Wiley & Sons, Ltd., vol. 22(6), pages 711-729, June.
    4. Ruoyan Sun & David Mendez, 2019. "Finding the optimal mix of smoking initiation and cessation interventions to reduce smoking prevalence," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-12, March.
    5. Lin, Wanchuan & Sloan, Frank, 2015. "Risk perceptions and smoking decisions of adult Chinese men," Journal of Health Economics, Elsevier, vol. 39(C), pages 60-73.
    6. Obinna Onwujekwe & Julia Fox-Rushby & Kara Hanson, 2008. "Construct Validity of the Bidding Game, Binary with Follow-up, and a Novel Structured Haggling Question Format in Determining Willingness to Pay for Insecticide-Treated Mosquito Nets," Medical Decision Making, , vol. 28(1), pages 90-101, January.
    7. Xiao-Hua Ying & Teh-Wei Hu & Jane Ren & Wen Chen & Ke Xu & Jin-Hui Huang, 2007. "Demand for private health insurance in Chinese urban areas," Health Economics, John Wiley & Sons, Ltd., vol. 16(10), pages 1041-1050.
    8. Harsman Tandilittin, 2016. "What should the Government do to Stop Epidemic of Smoking among Teenagers in Indonesia?," Asian Culture and History, Canadian Center of Science and Education, vol. 8(1), pages 140-140, March.
    9. Nihaya Al-Sheyab & Mahmoud A. Alomari & Smita Shah & Patrick Gallagher & Robyn Gallagher, 2014. "Prevalence, Patterns and Correlates of Cigarette Smoking in Male Adolescents in Northern Jordan, and the Influence of Waterpipe Use and Asthma Diagnosis: A Descriptive Cross-Sectional Study," IJERPH, MDPI, vol. 11(9), pages 1-16, September.
    10. Powdthavee, Nattavudh & van den Berg, Bernard, 2011. "Putting different price tags on the same health condition: Re-evaluating the well-being valuation approach," Journal of Health Economics, Elsevier, vol. 30(5), pages 1032-1043.
    11. Lars Hein & Pete Roberts & Lucia Gonzalez, 2016. "Valuing a Statistical Life Year in Relation to Clean Air," Journal of Environmental Assessment Policy and Management (JEAPM), World Scientific Publishing Co. Pte. Ltd., vol. 18(04), pages 1-24, December.
    12. Daniel Kuehnle & Christoph Wunder, 2017. "The Effects of Smoking Bans on Self‐Assessed Health: Evidence from Germany," Health Economics, John Wiley & Sons, Ltd., vol. 26(3), pages 321-337, March.
    13. Laia Soler & Nicolas Borzykowski, 2021. "The costs of celiac disease: a contingent valuation in Switzerland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(9), pages 1487-1505, December.
    14. Hugh Gravelle & Dave Smith, 2001. "Discounting for health effects in cost–benefit and cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 587-599, October.
    15. Carola Braun & Katrin Rehdanz & Ulrich Schmidt, 2016. "Validity of Willingness to Pay Measures under Preference Uncertainty," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-17, April.
    16. Ko, Hansoo, 2021. "Behavioral responses to the 2015 MERS epidemic in Korea," Economics & Human Biology, Elsevier, vol. 41(C).
    17. Frida Ngalesoni & George Ruhago & Mary Mayige & Tiago Cravo Oliveira & Bjarne Robberstad & Ole Frithjof Norheim & Hideki Higashi, 2017. "Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-20, August.
    18. Noar, Seth M. & Francis, Diane B. & Bridges, Christy & Sontag, Jennah M. & Ribisl, Kurt M. & Brewer, Noel T., 2016. "The impact of strengthening cigarette pack warnings: Systematic review of longitudinal observational studies," Social Science & Medicine, Elsevier, vol. 164(C), pages 118-129.
    19. Helen G. Levy & Edward C. Norton & Jeffrey A. Smith, 2018. "Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?," American Journal of Health Economics, MIT Press, vol. 4(1), pages 1-25, Winter.
    20. Richard D. Smith, 2007. "The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?," Health Economics, John Wiley & Sons, Ltd., vol. 16(12), pages 1319-1332.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:14:y:2016:i:4:d:10.1007_s40258-016-0239-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.